Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Wynn Resorts Ltd
WYNN
Consumer Cyclical
Resorts & Casinos
Wynn Resorts, Limited is a designer, developer, and operator of integrated resorts featuring luxury hotel rooms, high-end retail space, dining and entertainment options and gaming. Its segments include Wynn Palace, Wynn Macau, Las Vegas Operations, Encore Boston Harbor and Wynn Interactive. Its Wynn Palace is a luxury resort on the Cotai Strip in Macau, with approximately 1,706 guest rooms, suites and villas, 14 food and beverage outlets and meeting and convention space. Its Wynn Macau is a luxury resort located in the Macau Special Administrative Region of the People's Republic of China with approximately 1,010 guest rooms and suites, approximately 4 food and beverage outlets, convention space, and a performance lake, a rotunda shows and recreation and leisure facilities. The Company's Encore Boston Harbor is a luxury resort with approximately 671 hotel rooms, an spa, specialty shopping, 16 food and beverage outlets, nightclub and meeting spaces, waterfront park and floral displays.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
NDAQ:WYNN - Post by User
Wynn Resorts Ltd
<< Previous
Bullboard Posts
Next >>
(0)
•••
Maemae4
X
Post by
Maemae4
on Jun 03, 2022 5:31am
78 Views
Post# 34728785
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.
<< Previous
Bullboard Posts
Next >>
A leading-edge rare earth elements stock with no market recognition
Unlocking oil and gas opportunities globally and in the WCSB
A combined vision to grow a significant copper and gold company
This stock is ready to capture the lead in the diabetes market
Copper is on the rise and this company could be your gateway into the market
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
AI Beyond Hype: Real-world Applications and Possibilities
Gander Gold Discovers Significant Gold System at Lizard Pond Claims – Gander South Project
Pulsar Helium to Present and Host Open Q&A at the Emerging Growth Conference Dec. 7 – Register Now